Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine

Van Regenmortel MHV (2012)


Stellenbosse Instituut vir Gevorderde Navorsing (SIGNA)

Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to:

Journal Articles (subsidised)

Please refer to this item in SUNScholar by using the following persistent URL:
This item appears in the following collections: